DNTH vs VICI · rev $6.2M vs P/E 9.3, rev $3.85B
Dianthus Therapeutics Inc. (DNTH) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
DNTH currently screens at market cap $4.40B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the DNTH and VICI stock pages for the full models.
Not investment advice.